Dr. Irvin received a masters in biostatistics from the Medical University of South Carolina (MUSC) in Charleston and completed her doctoral degree in the Department of Epidemiology at UAB. She finalized her training in the UAB Section on Statistical Genetics as a postdoctoral fellow. Dr. Irvin joined the faculty at UAB in 2011. Her primary research interest is in pharmacogenetics of antihypertensive treatment with a focus on genetic risk for incident diabetes mellitus due to thiazide diuretic treatment and treatment resistant hypertension. Recent advancements in next-generation DNA sequencing technologies make sequencing the entire human genome accessible for patients in the forseeable future. Plus, the increasing use of electronic medical records will make unique aspects of an individual’s genetic make-up readily available to physicians. She aims to develop a program of research that will ultimately lead to the application of pharmacogenetics in the clinic for the optimization of antihypertensive treatment.